Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
ANTERIS TECHNOLOGIES GLOBAL (AVR) Stock Price & Overview
NASDAQ:AVR • US03675P1021
Current stock price
6.36 USD
+0.21 (+3.41%)
At close:
6.16 USD
-0.2 (-3.14%)
After Hours:
The current stock price of AVR is 6.36 USD. Today AVR is up by 3.41%. In the past month the price increased by 15.64%. In the past year, price increased by 43.57%.
AVR Key Statistics
52-Week Range2.85 - 6.9494
Current AVR stock price positioned within its 52-week range.
1-Month Range4.99 - 6.45
Current AVR stock price positioned within its 1-month range.
- Market Cap
- 618.383M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.55
- Dividend Yield
- N/A
AVR Stock Performance
Today
+3.41%
1 Week
+13.98%
1 Month
+15.64%
3 Months
+6.53%
Longer-term
6 Months +41.65%
1 Year +43.57%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
AVR Stock Chart
AVR Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to AVR. When comparing the yearly performance of all stocks, AVR is one of the better performing stocks in the market, outperforming 80.42% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
AVR Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AVR. AVR has a bad profitability rating. Also its financial health evaluation is rather negative.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AVR Earnings
On February 26, 2026 AVR reported an EPS of -0.74 and a revenue of 310.00K. The company missed EPS expectations (-24.18% surprise) and beat revenue expectations (53.47% surprise).
Next Earnings DateMay 11, 2026
Last Earnings DateFeb 26, 2026
PeriodQ4 / 2025
EPS Reported-$0.74
Revenue Reported310K
EPS Surprise -24.18%
Revenue Surprise 53.47%
AVR Forecast & Estimates
9 analysts have analysed AVR and the average price target is 15.5 USD. This implies a price increase of 143.77% is expected in the next year compared to the current price of 6.36.
For the next year, analysts expect an EPS growth of 52.05% and a revenue growth 251.8% for AVR
Analysts
Analysts80
Price Target15.5 (143.71%)
EPS Next Y52.05%
Revenue Next Year251.8%
AVR Index Membership
AVR is currently included in the following stock indexes tracked on ChartMill.
AVR Financial Highlights
Over the last trailing twelve months AVR reported a non-GAAP Earnings per Share(EPS) of -2.55. The EPS decreased by -20.15% compared to the year before.
Income Statements
Revenue(TTM)1.91M
Net Income(TTM)-94.14M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -409.38% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%-36.87%
Sales Q2Q%-42.17%
EPS 1Y (TTM)-20.15%
Revenue 1Y (TTM)-29.23%
AVR Ownership
Ownership
Inst Owners31.48%
Shares97.23M
Float79.50M
Ins Owners0.41%
Short Float %5.2%
Short Ratio4.62
AVR Industry Overview
AVR operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
60/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
22%
Outperformed 22% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 2.4%
- New Lows
- 14.2%
- Average ROE
- 17.2%
- Average Profit Margin
- 20.3%
- Average Operating Margin
- 22.5%
- Average P/E
- 28.1
- Average Fwd P/E
- 27.3
- Average Debt/Equity
- 0.5
AVR Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.25 | 162.529B | ||
| ABT | ABBOTT LABORATORIES | 14.24 | 157.763B | ||
| SYK | STRYKER CORP | 17.41 | 120.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.31 | 85.619B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.9 | 48.141B | ||
| IDXX | IDEXX LABORATORIES INC | 38.32 | 44.539B | ||
| BDX | BECTON DICKINSON AND CO | 10.94 | 42.438B | ||
| RMD | RESMED INC | 16.7 | 31.148B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.74 | 27.761B | ||
| DXCM | DEXCOM INC | 20.18 | 22.918B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.11 | 15.956B | ||
| PEN | PENUMBRA INC | 63.83 | 12.837B | ||
| GMED | GLOBUS MEDICAL INC - A | 20.03 | 12.197B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AVR
Company Profile
Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. The company is headquartered in Eagan, Minnesota and currently employs 174 full-time employees. The company went IPO on 2024-12-13. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.
Company Info
IPO: 2024-12-13
ANTERIS TECHNOLOGIES GLOBAL
860 Blue Gentian Road, Suite 340
Eagan MINNESOTA US
Employees: 174
Phone: 16514930606
ANTERIS TECHNOLOGIES GLOBAL / AVR FAQ
What does ANTERIS TECHNOLOGIES GLOBAL do?
Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. The company is headquartered in Eagan, Minnesota and currently employs 174 full-time employees. The company went IPO on 2024-12-13. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.
Can you provide the latest stock price for ANTERIS TECHNOLOGIES GLOBAL?
The current stock price of AVR is 6.36 USD. The price increased by 3.41% in the last trading session.
Does ANTERIS TECHNOLOGIES GLOBAL pay dividends?
AVR does not pay a dividend.
How is the ChartMill rating for ANTERIS TECHNOLOGIES GLOBAL?
AVR has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the sector and industry classification for ANTERIS TECHNOLOGIES GLOBAL?
ANTERIS TECHNOLOGIES GLOBAL (AVR) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the PE ratio for AVR stock?
ANTERIS TECHNOLOGIES GLOBAL (AVR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.55).
What is ANTERIS TECHNOLOGIES GLOBAL worth?
ANTERIS TECHNOLOGIES GLOBAL (AVR) has a market capitalization of 618.38M USD. This makes AVR a Small Cap stock.